From May 12, 2022 to June 30, 2022, the company has repurchased 797,000 shares, representing 0.14% for HKD 2.9 million. With this, the company has completed the repurchase of 797,000 shares, representing 0.14% for HKD 2.9 million under the buyback announced on May 12, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.56 HKD | +0.39% | -0.78% | +2.81% |
28/05 | Essex Bio-Technology Limited Declares Final Dividend for the Year Ended 31 December 2023 | CI |
19/03 | Essex Bio-Technology's 2023 Profit Jumps 22% on Higher Turnover | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.81% | 19Cr | |
+1.07% | 9.17TCr | |
0.00% | 3.94TCr | |
-10.35% | 3.45TCr | |
+64.64% | 2.67TCr | |
-16.15% | 1.51TCr | |
-6.98% | 1.33TCr | |
-11.77% | 1.17TCr | |
-49.19% | 1.05TCr | |
+8.09% | 941.14Cr |
- Stock Market
- Equities
- 1061 Stock
- News Essex Bio-Technology Limited
- Tranche Update on Essex Bio-Technology Limited's Equity Buyback Plan announced on May 12, 2022.